PMC:7376845 / 18855-19300 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T114","span":{"begin":63,"end":71},"obj":"Body_part"},{"id":"T115","span":{"begin":145,"end":155},"obj":"Body_part"},{"id":"T116","span":{"begin":197,"end":205},"obj":"Body_part"},{"id":"T117","span":{"begin":269,"end":276},"obj":"Body_part"},{"id":"T118","span":{"begin":320,"end":330},"obj":"Body_part"}],"attributes":[{"id":"A114","pred":"fma_id","subj":"T114","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A115","pred":"fma_id","subj":"T115","obj":"http://purl.org/sig/ont/fma/fma82739"},{"id":"A116","pred":"fma_id","subj":"T116","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A117","pred":"fma_id","subj":"T117","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A118","pred":"fma_id","subj":"T118","obj":"http://purl.org/sig/ont/fma/fma82739"}],"text":"We also studied the sequence diversity across 174 SARS-CoV-2 S proteins derived from nt sequences shared via the GISAID platform [27]. Only four amino-acid mutations were found within the putative antibody-binding region compared with 30 mutations over the full length protein (Supplementary Table 2). Two of these four amino-acid mutations are from a sequence flagged in GISAID’s EpiCoV database as lower quality due to many undetermined bases."}

{"project":"LitCovid-PubTator","denotations":[{"id":"470","span":{"begin":61,"end":62},"obj":"Gene"},{"id":"471","span":{"begin":50,"end":60},"obj":"Species"}],"attributes":[{"id":"A470","pred":"tao:has_database_id","subj":"470","obj":"Gene:43740568"},{"id":"A471","pred":"tao:has_database_id","subj":"471","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"We also studied the sequence diversity across 174 SARS-CoV-2 S proteins derived from nt sequences shared via the GISAID platform [27]. Only four amino-acid mutations were found within the putative antibody-binding region compared with 30 mutations over the full length protein (Supplementary Table 2). Two of these four amino-acid mutations are from a sequence flagged in GISAID’s EpiCoV database as lower quality due to many undetermined bases."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T165","span":{"begin":50,"end":58},"obj":"Disease"},{"id":"T166","span":{"begin":50,"end":54},"obj":"Disease"}],"attributes":[{"id":"A165","pred":"mondo_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A166","pred":"mondo_id","subj":"T166","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"We also studied the sequence diversity across 174 SARS-CoV-2 S proteins derived from nt sequences shared via the GISAID platform [27]. Only four amino-acid mutations were found within the putative antibody-binding region compared with 30 mutations over the full length protein (Supplementary Table 2). Two of these four amino-acid mutations are from a sequence flagged in GISAID’s EpiCoV database as lower quality due to many undetermined bases."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T186","span":{"begin":130,"end":132},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T187","span":{"begin":350,"end":351},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"We also studied the sequence diversity across 174 SARS-CoV-2 S proteins derived from nt sequences shared via the GISAID platform [27]. Only four amino-acid mutations were found within the putative antibody-binding region compared with 30 mutations over the full length protein (Supplementary Table 2). Two of these four amino-acid mutations are from a sequence flagged in GISAID’s EpiCoV database as lower quality due to many undetermined bases."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T164","span":{"begin":63,"end":71},"obj":"Chemical"},{"id":"T165","span":{"begin":145,"end":150},"obj":"Chemical"},{"id":"T166","span":{"begin":151,"end":155},"obj":"Chemical"},{"id":"T167","span":{"begin":269,"end":276},"obj":"Chemical"},{"id":"T168","span":{"begin":320,"end":325},"obj":"Chemical"},{"id":"T169","span":{"begin":326,"end":330},"obj":"Chemical"},{"id":"T170","span":{"begin":439,"end":444},"obj":"Chemical"}],"attributes":[{"id":"A164","pred":"chebi_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A165","pred":"chebi_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/CHEBI_46882"},{"id":"A166","pred":"chebi_id","subj":"T166","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A167","pred":"chebi_id","subj":"T167","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A168","pred":"chebi_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/CHEBI_46882"},{"id":"A169","pred":"chebi_id","subj":"T169","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A170","pred":"chebi_id","subj":"T170","obj":"http://purl.obolibrary.org/obo/CHEBI_22695"}],"text":"We also studied the sequence diversity across 174 SARS-CoV-2 S proteins derived from nt sequences shared via the GISAID platform [27]. Only four amino-acid mutations were found within the putative antibody-binding region compared with 30 mutations over the full length protein (Supplementary Table 2). Two of these four amino-acid mutations are from a sequence flagged in GISAID’s EpiCoV database as lower quality due to many undetermined bases."}

{"project":"LitCovid-sentences","denotations":[{"id":"T144","span":{"begin":0,"end":134},"obj":"Sentence"},{"id":"T145","span":{"begin":135,"end":301},"obj":"Sentence"},{"id":"T146","span":{"begin":302,"end":445},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We also studied the sequence diversity across 174 SARS-CoV-2 S proteins derived from nt sequences shared via the GISAID platform [27]. Only four amino-acid mutations were found within the putative antibody-binding region compared with 30 mutations over the full length protein (Supplementary Table 2). Two of these four amino-acid mutations are from a sequence flagged in GISAID’s EpiCoV database as lower quality due to many undetermined bases."}

{"project":"2_test","denotations":[{"id":"32700671-31565258-29327482","span":{"begin":130,"end":132},"obj":"31565258"}],"text":"We also studied the sequence diversity across 174 SARS-CoV-2 S proteins derived from nt sequences shared via the GISAID platform [27]. Only four amino-acid mutations were found within the putative antibody-binding region compared with 30 mutations over the full length protein (Supplementary Table 2). Two of these four amino-acid mutations are from a sequence flagged in GISAID’s EpiCoV database as lower quality due to many undetermined bases."}

{"project":"MyTest","denotations":[{"id":"32700671-31565258-29327482","span":{"begin":130,"end":132},"obj":"31565258"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"We also studied the sequence diversity across 174 SARS-CoV-2 S proteins derived from nt sequences shared via the GISAID platform [27]. Only four amino-acid mutations were found within the putative antibody-binding region compared with 30 mutations over the full length protein (Supplementary Table 2). Two of these four amino-acid mutations are from a sequence flagged in GISAID’s EpiCoV database as lower quality due to many undetermined bases."}